erythromycin has been researched along with alpha-aminopyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elmlinger, M; Hermann, R; Herzog, R; Huennemeyer, A; Lahu, G; McCracken, N; Zech, K | 1 |
| Chen, J; Chen, L; Guo, S; Lei, J; Xu, P; Xu, T; Yu, L; Yu, X; Zhou, X; Zhu, S | 1 |
1 trial(s) available for erythromycin and alpha-aminopyridine
| Article | Year |
|---|---|
Effect of repeated dose of erythromycin on the pharmacokinetics of roflumilast and roflumilast N-oxide.
Topics: Administration, Oral; Adult; Aminopyridines; Anti-Bacterial Agents; Area Under Curve; Benzamides; Cross-Over Studies; Cyclopropanes; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Erythromycin; Female; Humans; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Young Adult | 2009 |
1 other study(ies) available for erythromycin and alpha-aminopyridine
| Article | Year |
|---|---|
Metabolic interactions between flumatinib and the CYP3A4 inhibitors erythromycin, cyclosporine, and voriconazole.
Topics: Aminopyridines; Animals; Benzamides; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Erythromycin; Female; Humans; Male; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Voriconazole | 2020 |